Elissa Furutani

Title: Elissa Furutani: Innovator in Therapeutic Polypeptides

Introduction

Elissa Furutani is a prominent inventor based in Belmont, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic polypeptides. Her work focuses on innovative methods to treat various diseases and conditions.

Latest Patents

Elissa Furutani holds a patent for "Methods of using activin receptor type IIB variants." This invention features polypeptides that include an extracellular ActRIIB variant. In some embodiments, a polypeptide of the invention includes an extracellular ActRIIB variant fused to an Fc domain monomer or moiety. The invention also encompasses pharmaceutical compositions containing these polypeptides and methods of using them to treat diseases and conditions such as neuromuscular diseases, osteogenesis imperfecta, myelofibrosis, thrombocytopenia, neutropenia, and metabolic disease.

Career Highlights

Elissa is currently associated with Keros Therapeutics, Inc., where she continues to advance her research and development efforts. Her innovative approach has positioned her as a key figure in the biotechnology sector.

Collaborations

Elissa has collaborated with notable colleagues, including Jasbir S Seehra and Jennifer Lachey. These partnerships have further enhanced her research capabilities and contributed to her success in the field.

Conclusion

Elissa Furutani is a trailblazer in the development of therapeutic polypeptides, with a focus on addressing critical health challenges. Her contributions to biotechnology are paving the way for new treatment options and improving patient outcomes.